ES2157949T3 - Suspension oftalmica que contiene difluprednato. - Google Patents

Suspension oftalmica que contiene difluprednato.

Info

Publication number
ES2157949T3
ES2157949T3 ES94120480T ES94120480T ES2157949T3 ES 2157949 T3 ES2157949 T3 ES 2157949T3 ES 94120480 T ES94120480 T ES 94120480T ES 94120480 T ES94120480 T ES 94120480T ES 2157949 T3 ES2157949 T3 ES 2157949T3
Authority
ES
Spain
Prior art keywords
ophthalmic suspension
suspension containing
suspension
present
containing difluprednate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94120480T
Other languages
English (en)
Inventor
Motoko Kimura
Yasushi Morita
Takahiro Ogawa
Tadashi Terai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Mitsubishi Chemical Corp
Original Assignee
Senju Pharmaceutical Co Ltd
Mitsubishi Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd, Mitsubishi Chemical Corp filed Critical Senju Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2157949T3 publication Critical patent/ES2157949T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)

Abstract

UNA SUSPENSION OFTALMICA COMPRENDIENDO DIFLUPREDONATO COMO UN INGREDIENTE ACTIVO. LA SUSPENSION OFTALMICA DE LA PRESENTE INVENCION MUESTRA ACCION ANTIINFLAMATORIA Y ACCION ANTIALERGICA SUPERIOR POR LA ADMINISTRACION LOCAL. DE ACUERDO CON LA INVENCION, LA SUSPENSION DE LA PRESENTE INVENCION ES UTIL PARA EL TRATAMIENTO Y PREVENCION DE ENFERMEDADES DEL OJO, TALES COMO CONJUNTIVITIS ALERGICA, CONJUNTIVITIS VERNAL, BLEFARITIS MARGINALES, CONJUNTIVITIS CATARRAL Y UVEITIS.
ES94120480T 1993-12-27 1994-12-23 Suspension oftalmica que contiene difluprednato. Expired - Lifetime ES2157949T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP33209993 1993-12-27

Publications (1)

Publication Number Publication Date
ES2157949T3 true ES2157949T3 (es) 2001-09-01

Family

ID=18251141

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94120480T Expired - Lifetime ES2157949T3 (es) 1993-12-27 1994-12-23 Suspension oftalmica que contiene difluprednato.

Country Status (10)

Country Link
US (1) US5556848A (es)
EP (1) EP0659433B1 (es)
KR (1) KR950016758A (es)
CN (1) CN1122225A (es)
AT (1) ATE202477T1 (es)
AU (1) AU684115B2 (es)
CA (1) CA2138741A1 (es)
DE (1) DE69427573T2 (es)
ES (1) ES2157949T3 (es)
TW (1) TW327602B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10251131A (ja) * 1997-03-11 1998-09-22 Sunstar Inc 口腔用組成物
EP0878197B1 (en) * 1997-05-14 2002-08-21 Senju Pharmaceutical Co., Ltd. Compositions containing difluprednate
WO1998057646A1 (fr) * 1997-06-19 1998-12-23 Senju Pharmaceutical Co., Ltd. Preparations medicinales aqueuses a base de difluprednate solubilise destinees a un usage externe
JP4255656B2 (ja) * 2001-09-17 2009-04-15 株式会社メニコン 眼科用液剤及びコンタクトレンズ用液剤
DK1532981T3 (da) * 2002-08-23 2008-01-28 Santen Pharmaceutical Co Ltd Stabile öjendråber, der indeholder latanoprost som den aktive bestanddel
MXPA05008396A (es) * 2003-02-20 2006-03-30 Alcon Inc Formulaciones de glucocorticoides para tratar angiogenesis ocular patologica.
US20050084454A1 (en) * 2003-10-14 2005-04-21 Sinofresh Healthcare, Inc. Compositions and methods for cleaning nasal cavities
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
FR2891460B1 (fr) * 2005-09-30 2010-07-30 Galderma Sa Utilisation d'au moins un compose de la famille des avermectines pour le traitement des pathologies ophtalmiques dues au demodex folliculorum.
JP2009535342A (ja) * 2006-04-26 2009-10-01 アーシエックス， インコーポレイテッド 眼瞼腫脹の予防および処置のための組成物
TWI415629B (zh) 2006-10-26 2013-11-21 Otsuka Pharma Co Ltd 含有瑞巴匹特之水性醫藥懸浮物及其製造方法
TW201105363A (en) 2009-07-14 2011-02-16 Univ Yamagata Eye drop for macular edema treatment
WO2013098841A1 (en) 2011-10-31 2013-07-04 Fdc Limited Nanodispersion of poorly water soluble drug(s)
PL3250185T3 (pl) * 2015-01-26 2019-05-31 Bausch & Lomb Oftalmiczna kompozycja zawiesinowa
US11000475B2 (en) 2015-10-16 2021-05-11 Sun Pharma Advanced Research Company Limited Ophthalmic solution of difluprednate
WO2017193060A1 (en) * 2016-05-05 2017-11-09 Veloce Biopharma, Llc Compositions and methods for treatment of inflammation or infection of the eye
JP6941157B2 (ja) * 2016-05-06 2021-09-29 サックシュ・コーポレーション 眼科用組成物
JP2024501425A (ja) * 2020-12-03 2024-01-12 サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド 眼炎症の有害作用を軽減するためのジフルプレドナート

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3780177A (en) * 1967-06-16 1973-12-18 Warner Lambert Co 17-butyrate,21-ester derivatives of 6alpha,9alpha-difluoroprednisolone,compositions and use
US3784692A (en) * 1967-06-16 1974-01-08 Warner Lambert Co 17-propionate,21-ester derivatives of 6alpha,9alpha-difluoroprednisolone,compositions and use
US4304765A (en) * 1980-10-14 1981-12-08 Alza Corporation Ocular insert housing steroid in two different therapeutic forms
US4478818A (en) * 1982-12-27 1984-10-23 Alza Corporation Ocular preparation housing steroid in two different therapeutic forms
JPS61167614A (ja) * 1985-01-22 1986-07-29 Mitsubishi Yuka Yakuhin Kk ステロイド含有軟膏剤
US5407926A (en) * 1987-12-29 1995-04-18 Alcon Laboratories, Inc. Ophthalmic composition
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5360611A (en) * 1988-10-03 1994-11-01 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following ultraviolet laser irradiation
JPH0543465A (ja) * 1991-08-08 1993-02-23 Mitsubishi Kasei Corp コルチコステロイド含有ローシヨン剤

Also Published As

Publication number Publication date
ATE202477T1 (de) 2001-07-15
AU684115B2 (en) 1997-12-04
TW327602B (en) 1998-03-01
AU8160194A (en) 1995-07-06
EP0659433A1 (en) 1995-06-28
US5556848A (en) 1996-09-17
EP0659433B1 (en) 2001-06-27
DE69427573D1 (de) 2001-08-02
CN1122225A (zh) 1996-05-15
KR950016758A (ko) 1995-07-20
DE69427573T2 (de) 2002-04-25
CA2138741A1 (en) 1995-06-28

Similar Documents

Publication Publication Date Title
ES2157949T3 (es) Suspension oftalmica que contiene difluprednato.
ATE227976T1 (de) Lösungen als träger für augenarzneien
ES2182973T3 (es) Metodo para reducir la presion intraocular enel ojo de mamifero por administracion de bloqueadors de canal de potasio.
MXPA06014470A (es) Formulaciones oftalmicas que incluyen antagonistas de alfa 1 selectivas.
ES2154262T3 (es) Uso de compuestos macrolidos para enfermedades oculares.
BR0012387A (pt) Composição para tratamento de distúrbios de secreção externa
AR034619A1 (es) Formulaciones de olopatadine para administracion topica
AR031135A1 (es) Composiciones de antibiotico topico para el tratamiento de infecciones oculares
ECSP12012037A (es) Composiciones oftálmicas no irritantes de iodopovidona
MX2024004131A (es) Ciertos 2,5-diazabiciclo[4.2.0]octanos como moduladores del receptor de glp-1.
MX2020006309A (es) Fórmulaciones de parasiticida de isoxazolina y métodos para el tratamiento de la blefaritis.
WO2006097337A3 (en) 11β-HYDROXYSTEROID DEHYDROGENASES
BR0012696A (pt) Composição oftálmica
WO2004030524A3 (en) Treatment of autism and similar disorders
DK1110554T3 (da) Medicinal præparater til behandling af öjensygdomme
WO2000018387A3 (en) Antibiotic compositions for treatment of the eye, ear and nose
DOP2003000747A (es) Composiciones oftalmicas para el tratamiento de la hipertension ocular
BR9914848A (pt) Composição e processo para o tratamento de distúrbios da retina externa
PE20061167A1 (es) Composicion farmaceutica que comprende moduladores de fosfodiesterasa pde4
PL369607A1 (en) Superoxide dismutase mimics for the treatment of ocular disorders and diseases
BRPI0517972A (pt) ácido 5,6,7-triidroxiheptanóico e análogos para o tratamento de doenças oculares e doenças associadas com respostas hiperproliferativas e angiogênicas
ES2061821T3 (es) Utilizacion terapeutica del derivado ester isopropilo de monosialgangliosido en patologias nerviosas con componente inflamatoria.
ES2196171T3 (es) Agentes antitumorales de tioxantenona liofilizada.
MX9303443A (es) Alquiliden-hidroxilaminas azaciclicas y azabiciclicas, proceso para su preparacion y composiciones farmaceuticas que las contienen.
HUP0204180A2 (hu) Külsőleges készítmény és alkalmazása allergiás dermatitisz kezelésére

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 659433

Country of ref document: ES